Study to Assess Safety, Tolerability, PK, and PD of Multiple Doses of ZE63-0302 Administrated Orally in T2DM Patients.
Clinical trial NCT07234864 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07234864
- Sponsor
- Eilean Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-19
- Primary completion
- 2026-04-21
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.